Comprehensive M&A data with integrated detailed company information
Nexus Health launches with Nexus Oncology deal
Posted on Thursday, 21 May 2020 10:41
M2 Health Media has acquired US-based oncology education and strategy consultancy Nexus Oncology for an undisclosed sum.
Following the deal, the buyer has renamed itself Nexus Health Media and the target will be relaunched as a subsidiary of the company as the first of seven health verticals.
Nexus Oncology partners with medical, pharmaceutical and healthcare experts to provide data to oncologists worldwide.
The group delivers up-to-date information to help physicians make the best clinical decisions for treating patients with cancer.
Its offerings include detailed perspective reports, video vignettes, seminars and private interviews, among other resources.
Over the next 90 days, Nexus Oncology’s website will provide up-to-date cancer care news with a user-friendly navigation function, allowing physicians to retrieve data at their own convenience.
Through the site, doctors will also be able to receive scientific and medical updates from the American Society of Clinical Oncology.
Mike Gramling, chief executive of Nexus Health, said: “Instead of physicians having to seek out and go get the most timely, trusted and credible information, the Nexus platforms put it at their fingertips.
“Building a network of key opinion leaders and community oncologists, making it easier for them to connect and stay informed, will ultimately make the lives of patients and their families better.”
Following this deal, Nexus Health’s next verticals will be in haematology and cardiology.
According to Zephyr, the M&A database published by Bureau van Dijk, there have been 2,045 deals targeting companies operating in the research and development in the physical, engineering and life sciences industries announced globally in 2020 to date.
The largest of these took the form of an acquisition and involved Gilead Sciences buying US-based Forty Seven for USD 4.90 billion.
In the second-biggest deal, China’s WuXi AppTec announced its plans to raise HKD 13.19 billion (USD 1.70 billion) through a private placement.
© Zephus Ltd